Beyond Pharmacology: The Biological Mechanisms of Remote Ischemic Conditioning in Cerebrovascular Disease

Linhui Qin1, Fang Tong1, Sijie Li1

  • 1Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

Biomolecules
|November 27, 2024
PubMed

Insights

Remote ischemic conditioning (RIC) offers a non-drug approach to protect the brain from cerebrovascular diseases (CVDs) like stroke. This method activates natural defenses, aiding recovery and potentially enhancing other treatments.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • Cerebrovascular diseases (CVDs), including stroke and chronic cerebral hypoperfusion (CCH), are leading causes of death and disability worldwide.
  • Current treatments for CVDs have limitations, highlighting the need for novel therapeutic strategies.
  • Remote ischemic conditioning (RIC) is a non-pharmacological intervention showing promise for neuroprotection.

Purpose of the Study:

  • To review the neuroprotective mechanisms of RIC in the context of cerebrovascular diseases.
  • To explore the efficacy of RIC during acute and chronic phases of stroke recovery.
  • To investigate the synergistic effects of RIC with other therapies and its peripheral transmission pathways.

Main Methods:

  • Comprehensive literature review of studies on remote ischemic conditioning and cerebrovascular diseases.
  • Analysis of neuroprotective mechanisms, including acute and chronic effects post-stroke.
  • Examination of combined therapeutic strategies and peripheral signaling pathways.

Main Results:

  • RIC activates endogenous defense mechanisms conferring neuroprotection against CVDs.
  • RIC demonstrates benefits in both acute stroke management and chronic recovery phases.
  • Synergistic effects observed when RIC is combined with pharmacological treatments and exercise.

Conclusions:

  • RIC is a promising non-pharmacological strategy for managing cerebrovascular diseases.
  • Further research is needed to standardize RIC protocols and identify biomarkers.
  • Expanded clinical trials are essential to validate RIC's therapeutic potential and guide clinical application.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...